# YSB

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ysb

- Industry: Healthcare IT
- Headquarters: Guangzhou, China
- Website: www.ysbang.cn
- Total disclosed funding: $495M
- Latest round: Series E (Jun 15, 2021)
- Investors on record: 15

## About

Founded in 2012, and based in Guangzhou, China, YSB Inc. previously named Speedroad Medical Information Co., Ltd., is a healthcare IT company that operates a medical transaction platform. Its services covered 354,000 pharmacies and 173,000 primary healthcare institutions, among which the average monthly active buyers reach 308,000. In 2015, the company released the Pharmacist Help APP. In 2020, the company will make its live broadcast debut on the Pharmacist Help APP, and sold over CNY 2 million in 60 minutes. In 2023, it was listed on Hong Kong Stock Exchange under the number 09885.

The company provides drugs transaction platform, Pharmacist Help, for the out-of-hospital pharmaceutical market, including pharmaceutical companies, distributors, vendors, pharmacies and primary healthcare institutions. The Pharmacist Help include following modules, SaaS for pharmaceutical company, SaaS for pharmaceutical sellers, SaaS for pharmacies standard, SaaS for pharmacies Pro version of ePalm. The SaaS for pharmaceutical sellers include smart supply chain systems, and financial systems. The SaaS for pharmacies include storage systems, micro store systems, smart cashier systems, YSB cloud synchronization systems, and purchase, sale, and inventory management systems. 

As of December 2022, its revenue is CNY 14.274 billion, and its net income is CNY -1.496 billion.

## Funding rounds

- Series E, Jun 15, 2021, $270M — Green Pine Capital Partners, Sunshine Insurance Group, Sfund, Baidu Ventures, Beijing Pearl River Real Estate Development
- Series D, Dec 16, 2018, $133M — DCM, H Capital, Tiger Global Mauritius Fund
- Series C, Jun 14, 2018, $66M — DCM, SIG Asia Investment, Green Pine Capital Partners, ECC Capital, Shunwei Capital
- Series B, Feb 8, 2017, $16M — Fosun International, Green Pine Capital Partners, Co-Power Venture Capital, Ivy Capital
- Series A, Apr 5, 2016, $11M — Fosun International, Ivy Capital, Bat Capital

## Investors

- Fosun International (https://capitalatlas.ai/funds/fosun-international) — Series A, Series B
- Ivy Capital (https://capitalatlas.ai/funds/ivy-capital) — Series A, Series B
- Bat Capital (https://capitalatlas.ai/funds/bat-capital) — Series A
- Green Pine Capital Partners (https://capitalatlas.ai/funds/green-pine-capital-partners) — Series B, Series C, Series E
- Co-Power Venture Capital (https://capitalatlas.ai/funds/co-power-venture-capital) — Series B
- DCM (https://capitalatlas.ai/funds/dcm) — Series C, Series D
- SIG Asia Investment (https://capitalatlas.ai/funds/sig-asia-investment) — Series C
- ECC Capital (https://capitalatlas.ai/funds/ecc-capital) — Series C
- Shunwei Capital (https://capitalatlas.ai/funds/shunwei-capital) — Series C
- H Capital (https://capitalatlas.ai/funds/h-capital) — Series D
- Tiger Global Mauritius Fund — Series D
- Sunshine Insurance Group — Series E
- Sfund (https://capitalatlas.ai/funds/sfund) — Series E
- Baidu Ventures (https://capitalatlas.ai/funds/baidu-ventures) — Series E
- Beijing Pearl River Real Estate Development — Series E